Detection and Direct Genomic Sequencing of Multiple Rare Unknown Flanking DNA in Highly Complex Samples-Reference-Cited by-同舟云学术

Detection and Direct Genomic Sequencing of Multiple Rare Unknown Flanking DNA in Highly Complex Samples

Published:2001-05 Issue:7 Volume:12 Page:743-749
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Schmidt Manfred¹,Hoffmann Gesa¹,Wissler Manuela¹,Lemke Nina¹,Müßig Arne¹,Glimm Hanno¹,Williams David A.²,Ragg Susanne²,Hesemann Claus-Ulrich³,von Kalle Christof¹

Affiliation:

1. Department I of Internal Medicine, University of Freiburg, 79106 Freiburg, Germany

2. Section of Pediatric Hematology/Oncology, Herman B. Wells Center for Pediatric Research, Riley Hospital for Children, Indianapolis, IN 46202 and Howard Hughes Medical Institute, Indiana University School of Medicine, Indianapolis, IN 46202

3. Institute of Genetics, University of Hohenheim, 70599 Stuttgart, Germany

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/104303401750148649

Reference30 articles.

1. Chapter 5 Retrovirus-Mediated Insertional Mutagenesis in Zebrafish

2. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases

3. Gene therapy turns the corner

4. Gene Marking and Gene Therapy for Transplantation Medicine

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article;Human Gene Therapy;2024-08-01

2. Restoration of T and B Cell Differentiation after RAG1 Gene Transfer in Human RAG1 Defective Hematopoietic Stem Cells;Biomedicines;2024-07-05

3. Prenatal AAV9-GFP administration in fetal lambs results in transduction of female germ cells and maternal exposure to virus;Molecular Therapy - Methods & Clinical Development;2024-06

4. PCR-based genome walking methods (review);Ecological genetics;2024-05-14

5. Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies;Mutation Research - Genetic Toxicology and Environmental Mutagenesis;2024-05